ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657598 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657598; 2) Community: the network communities that were significantly associated with the response to NSC 657598; 3) Molecule: the relationships between components within communities and NSC 657598; 4) MDR: the compounds that were significantly associated with the NSC 657598.

NSC Compound Enrichment Correlation
NSC 102067 6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 0.035202825328704 0.2363357
NSC 365798 Fostamatinib disodium, Tamatinib fosdium 0.035202825328704 0.31538046
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.035202825328704 -0.12592539
NSC 626176 Null 0.035202825328704 0.11022206
NSC 644259 Null 0.035202825328704 0.12986422
NSC 649107 Null 0.035202825328704 -0.21596033
NSC 670803 1-Octene, 3-(bromomethyl)-2,3,7-trichloro-7-methyl- 0.0352028253287042 0.031920578
NSC 676794 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy 0.0352028253287042 -0.017961617
NSC 678106 Rhamnazin 0.0352028253287042 0.20113938
NSC 689626 Null 0.0352028253287042 0.081756105
Total:29  Current:17    [First] [Prev] [Next] [Last]